Kynd Revenue and Competitors

Gold Coast,

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Kynd's estimated annual revenue is currently $2.2M per year.(i)
  • Kynd's estimated revenue per employee is $101,500

Employee Data

  • Kynd has 22 Employees.(i)
  • Kynd grew their employee count by -21% last year.

Kynd's People

NameTitleEmail/Phone
1
Senior Product ManagerReveal Email/Phone
2
Support SpecialistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$60M33124%N/AN/A
#2
$5.3M46-6%N/AN/A
#3
$36.8M236-3%$46.9MN/A
#4
$15.1M1044%N/AN/A
#5
$1.4M16-6%N/AN/A
#6
$1.4M16-6%N/AN/A
#7
$3.5M30-12%N/AN/A
#8
$146M7196%N/AN/A
#9
$99.7M550-1%N/AN/A
#10
$12.9M89-3%$3.5MN/A
Add Company

What Is Kynd?

The simple way to find and book #NDIS support.

keywords:N/A

N/A

Total Funding

22

Number of Employees

$2.2M

Revenue (est)

-21%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Kynd News

2022-04-19 - Urgent recall for popular chemist buy

A batch of anti-anxiety medication has been recalled by Australia's peak medical regulatory body following reports of unexpected allergic...

2022-04-19 - Urgent recall for popular chemist buy

A batch of anti-anxiety medication has been recalled by Australia's peak medical regulatory body following reports of unexpected allergic...

2022-04-19 - Anti-anxiety medication recalled

The allergic reaction symptoms to watch out for include a rash, tingling or burning skin, skin redness or itching, and swelling of the...

2022-04-19 - Anti-anxiety medication recalled

The allergic reaction symptoms to watch out for include a rash, tingling or burning skin, skin redness or itching, and swelling of the...

2022-04-17 - Ayr Wellness Announces the Launch of Kynd Premium Flower ...

Sales of Kynd began this week across Liberty's 45-dispensary footprint. The initial launch includes six strain offerings, namely “Blueberry...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3.1M26-38%N/A
#2
$3.1M274%N/A
#3
$5.1M313%N/A
#4
$3.9M34-8%N/A
#5
$5.8M36-23%N/A